ChemicalBook > CAS DataBase List > Solanezumab
Solanezumab
- Product Name
- Solanezumab
- CAS No.
- 955085-14-0
- Chemical Name
- Solanezumab
- Synonyms
- Solanezumab;Research Grade Solanezumab;Research Grade Solanezumab (DHC12505)
- CBNumber
- CB72657946
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Solanezumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Solanezumab Chemical Properties,Usage,Production
Uses
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1].
References
[1] [1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. N Engl J Med. 2018 Jan 25;378(4):321-330. DOI:10.1056/NEJMoa1705971
Solanezumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Solanezumab Suppliers
- Tel
- info@creative-peptides.com
- Country
- United States
- ProdList
- 6083
- Advantage
- 56
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 17705183659
- Fax
- 84523390
- sales@njleonbiotech.com
- Country
- China
- ProdList
- 5501
- Advantage
- 55
- Tel
- 025-58361106-805 15951641583
- Fax
- 025-58361106-806
- zhao.xu@njpeptide.com
- Country
- China
- ProdList
- 9979
- Advantage
- 55
- Tel
- meitaochem@126.com
- meitaochem@126.com
- Country
- China
- ProdList
- 19103
- Advantage
- 58
- Tel
- 16314854226; +16314854226
- inquiry@bocsci.com
- Country
- United States
- ProdList
- 19654
- Advantage
- 58
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 15871722230
- Fax
- 2796190295
- 15871722230@163.com
- Country
- China
- ProdList
- 4686
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
955085-14-0, SolanezumabRelated Search:
Ranibizumab
CETUXIMAB
Adalimumab
Trastuzumab
Rituximab
Bevacizumab
Nivolumab
dupilumab
Zagotenemab
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer